Magenta Therapeutics, Inc. Gains 29.77%
Thu, Jul 07, 2022 at 08:37 PM
Magenta Therapeutics, Inc. (MGTA:NASDAQ) jumped higher at $1.7, a gain of 29.8%. On Thu, Jul 07, 2022, MGTA:NASDAQ touched a New 2-Week High of $1.7. From Thu, Jun 23, 2022, the stock recorded 44.44% Up Days and 50.00% Green Days
About Magenta Therapeutics, Inc. (MGTA:NASDAQ)
Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to bring the curative power of bone marrow transplant.
Top 10 Gainers:
- Grove Collaborative Holdings Inc. Class A (GROV:NYSE), 84.25%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Kiromic BioPharma Inc. (KRBP:NASDAQ), 43.46%
- AcelRx Pharmaceuticals, Inc. (ACRX:NASDAQ), 36.2%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 32.73%
- Magenta Therapeutics, Inc. (MGTA:NASDAQ), 29.77%
- Sphere 3D Corp. (ANY:NASDAQ), 29.46%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 27.38%
- Kubient Inc. (KBNT:NASDAQ), 27.04%
- iSpecimen Inc. (ISPC:NASDAQ), 24.89%